findmyKOL

David Kandzari, MD

Enriched profile

Chief, Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology; Chief Scientific Officer, Piedmont Healthcare · Piedmont Heart Institute

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Atlanta, GA · Southeast · United StatesSpecialtyInterventional CardiologyFocusCoronary Interventions and Diagnostics+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

David Kandzari is Chief, Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology; Chief Scientific Officer, Piedmont Healthcare at Piedmont Heart Institute. OpenAlex indexes 670 publications with 29,091 citations (h-index 82); ClinicalTrials.gov lists 32 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Interventional Cardiology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 16 Oct 2026

David Kandzari, MD, is Chief, Piedmont Heart Institute and Cardiovascular Service Line. The public record shows 670 publications with 29,091 citations (h-index 82), centered on Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Blood Pressure and Hypertension Studies. It also documents an investigator role on 32 registered clinical trials, industry payments reported by 25 companies.

  • Most recent indexed publication: 2026 · Circulation. Cardiovascular interventions
  • Top research focus: Coronary Interventions and Diagnostics
  • 32 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Coronary Artery Disease / ACS17 trialsCoronary Artery Disease17 trialsHypertension8 trialsCardiovascular Diseases8 trialsVascular Diseases8 trialsMyocardial Ischemia8 trialsIschemia5 trialsChronic Kidney Disease2 trialsRenal Insufficiency, Chronic2 trialsAtherosclerosis2 trialsAcute Coronary Syndrome2 trialsAngina Pectoris2 trialsPeripheral Arterial Disease1 trialThrombosis1 trialCoronary Thrombosis1 trialCoronary Stenosis1 trialConstriction, Pathologic1 trial

Research focus

OpenAlex concept fingerprint
Coronary Interventions and DiagnosticsCardiac Imaging and DiagnosticsBlood Pressure and Hypertension StudiesAcute Myocardial Infarction ResearchPeripheral Artery Disease Management

Drugs & molecules

across trials, industry payments and publications
Eliquisgeneric · ApixabanClinical trials—Industry payments4Publications—NirmatrelvirClinical trials—Industry payments2Publications—Rybelsusgeneric · SemaglutideClinical trials—Industry payments2Publications—Verquvogeneric · VericiguatClinical trials—Industry payments2Publications—Nexletolgeneric · Bempedoic acidClinical trials—Industry payments1Publications—RimegepantClinical trials—Industry payments1Publications—Vyndaqelgeneric · TafamidisClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Boston Scientific CorporationClinical trials2Industry payments29Ablative Solutions, Inc.Clinical trials2Industry payments16Biotronik, Inc.Clinical trials2Industry payments10Cordis US Corp.Clinical trials1Industry payments8Shockwave Medical, Inc.Clinical trials1Industry payments8Asahi Intecc USA IncClinical trials1Industry payments1Medtronic, Inc.Clinical trials—Industry payments269Cardiovascular Systems Inc.Clinical trials—Industry payments36Abbott LaboratoriesClinical trials—Industry payments20Teleflex LLCClinical trials—Industry payments10Medtronic VascularClinical trials8Industry payments—Terumo Medical CorporationClinical trials—Industry payments4OrbusNeichClinical trials3Industry payments—Pfizer Inc.Clinical trials—Industry payments3Abbott Medical DevicesClinical trials2Industry payments—E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments2Magenta Medical IncClinical trials—Industry payments2Philips Electronics North America CorporationClinical trials—Industry payments2Siemens Medical Solutions USA, Inc.Clinical trials—Industry payments2Vascular Solutions LLCClinical trials2Industry payments—Amplitude Vascular Systems, Inc.Clinical trials—Industry payments1Arrow Interventional, Inc.Clinical trials—Industry payments1Cagent Vascular INCClinical trials—Industry payments1ECRI bvClinical trials1Industry payments—Edwards Lifesciences CorporationClinical trials—Industry payments1Esperion Therapeutics, Inc.Clinical trials—Industry payments1Medtronic EndovascularClinical trials1Industry payments—Merck Sharp & Dohme LLCClinical trials—Industry payments1Micell TechnologiesClinical trials1Industry payments—Novo Nordisk IncClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
670publications

Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.

29,091citations

Total citations across indexed works.

82h-index

Hirsch index (OpenAlex). i10-index 266.

Clinical & industry

trials, payments and federal funding
32clinical trials

Investigator role on registered studies.

View trials ↓
25companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record
  • Voting member

    FDA Circulatory System Devices Panel meeting

    2016
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fda.gov ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 32 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    75.9%
    Statin25.2%
    Rosuvastatin Calcium69%Atorvastatin Calcium28%Simvastatin3%
    Part D<11 patients
    Beta blocker12.7%
    Metoprolol Succinate60%Metoprolol Tartrate19%Carvedilol15%Atenolol6%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    23.4%
    P2Y12 inhibitor19.7%
    Clopidogrel86%Prasugrel Hcl12%Brilinta3%
    Part D<11 patients
    Factor Xa inhibitor3.7%
    Eliquis100%
    Part D≥22 patients
  • Metabolism & gastrointestinal

    0.7%
    Potassium supplement0.7%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)60.7% facility · 39.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Gregg W. Stone139Ajay J. Kirtane123Nicholas Lembo122Emmanouil S. Brilakis108Dimitri Karmpaliotis104Khaldoon Alaswad94Felix Mahfoud88Martin B. Leon88Farouc A. Jaffer86Jeffrey W. Moses86Roxana Mehran85Robert W. Yeh85William Lombardi83Bavana V. Rangan74Anthony Doing68Raymond R. Townsend67Patrick W. Serruys65Mitul Patel65A. Pieter Kappetein62Joseph F. Sabik62Craig A. Thompson62Santiago García62Michael A. Weber59R. Michael Wyman59James W. Choi58Ziad A. Ali58Roland E. Schmieder57Michael Böhm56J. Aaron Grantham52Manish Parikh52Subhash Banerjee51Stephan Windecker50Judit Karácsonyi48Catalin Toma48Ori Ben‐Yehuda48Martin Fahy43Barry F. Uretsky43Ovidiu Dressler41Kazuomi Kario41Aris Karatasakis41

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/david-kandzari-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/david-kandzari-41b5908

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/David-E-Kandzari-39795224

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/Kandzari

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    pcronline.com/Physicians/David-Kandzari

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pcronline.com ↗
  • Other

    scai.org/david-e-kandzari-md-mscai

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Duke University Medical Center (1995); internship in cardiology, The Johns Hopkins Hospital (1996); residency, Johns Hopkins University School of Medicine (1998); fellowship in Interventional Cardiology …

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →care.piedmont.org ↗
  • Board certified

    American Board of Internal Medicine - Cardiovascular Disease subspecialty and Interventional Cardiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →care.piedmont.org ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Advisor

    European Cardiovascular Research Institute (ECRI)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ecri-trials.com ↗
  • Leadership team

    AVS Pulse, Inc.

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →avspulse.com ↗

Media & interviews

press, podcasts and appearances
  • Guest

    Sensei Podcast Episode 107 - discussion of CTO and complex PCI

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tctmd.com ↗
  • Guest

    Living Real Change Podcast Episode Ten (Piedmont Healthcare) discussing heart health

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.